India Oligonucleotides Synthesis Market – Industry Trends and Forecast to 2030

India Oligonucleotides Synthesis Market Analysis and Size

The India oligonucleotides synthesis market is expected to grow in the forecast year due to the rise in the number of market players and the availability of advanced technological devices. The increasing development in the field of advanced techniques is further expected to boost market growth. However, difficulties such as the stringent regulations for the production and commercialization of products are expected to restrain market growth in the forecast period.

Data Bridge Market Research analyzes that, India oligonucleotides synthesis market is expected to reach the value of USD 191.35 million by 2030, at a CAGR of 7.4% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.

Market Definition

Oligonucleotides can be formed either enzymatically through the cleavage of larger biomolecules or targeted chemical synthesis. In the latter case, organonucleotide synthesis is the chemical process by which nucleoside phosphoramidites – a key monomeric element of oligonucleotides – are synthesized. Nucleoside phosphoramidites (also known as nucleosides or amidites) themselves are derivatives of natural or synthetic nucleosides. Oligonucleotide synthesis is the chemical process by which nucleotides are specifically linked to form the desired sequenced product. Continuous solid phase synthesis using a packed-bed column is commonly used for producing oligonucleotides. In some cases, a batch, slurry reaction is employed.

India Oligonucleotides Synthesis market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Use of Synthesized Oligonucleotides in Various Applications

Many technologies have been developed to improve oligonucleotide pharmacokinetics and pharmacodynamics. The field of oligonucleotides synthesis has seen significant advancements in recent years with the advent of oligos. With diversifying applications, India oligonucleotides synthesis market presents a significant opportunity for growth. The massive and cheap oligos produced by large-scale oligo synthesis can be used for many purposes, enabling numerous interesting applications. For example, the oligos can be used for the constructions of large cell populations or DNA variations, which are beneficial in engineering regulatory elements, genetic networks, metabolic pathways, and DNA origami.

Oligonucleotides synthesis allows performing precise and targeted procedures without the need for traditional methods. For most applications, very small quantities of DNA are required, and oligonucleotide synthesis is performed mainly on the 40 nmol scale or lower. This provides ample quantities for most biochemical and biological experiments. Much larger amounts of DNA 10 µmol or more can be prepared for use in biophysical studies nuclear magnetic resonance and X-ray crystallography.

Thus, the use of synthesized oligonucleotides in various applications is expected to present significant growth in the India oligonucleotides synthesis market.

• Increasing Government Investments and R&D Expenditure

The benefits of oligonucleotides synthesis can lead to increased demand for various testing methods. The advantages of quick results, reduced turnaround times, and improved patient care, there is a greater likelihood of healthcare providers incorporating oligonucleotides synthesis into their practices. This increased demand can drive the growth of the oligonucleotides synthesis market. The government, federations, and major players in the market are involved in spreading awareness among society across developing countries. These initiatives by the players and government are helping the users to reach out and take advantage of the policies made for low-income and developing nations. The growth of oligonucleotides synthesis in pharmaceutical companies and forensic labs is already strongly encouraged by government initiatives and the prevalence of time-sensitive medical diseases.

Thus, these steps by the federations, associations, and healthy trending laboratories including the government are involved in spreading awareness and also helping the newly established authorities to take structural decisions for improving diagnostics and research. Thus, the increasing Government Investments and R&D Expenditure are expected to drive market growth.

Opportunity

 Rising Technological Advancements

To address the constantly changing needs of many industries, technological breakthroughs in Oligonucleotides synthesis are giving considerable increases in their performance, durability, and versatility. These developments are changing the way surface protection is practiced, providing users with better security and ease.

The substantial rise in technological advancements in India presents a significant opportunity for growth within the Oligonucleotides synthesis market. Oligonucleotides synthesis stands out as a pivotal tool for advancing precision medicine and personalized treatments as the country allocates increasing resources to enhance its healthcare infrastructure and address a range of medical challenges. The heightened investment in healthcare translates into greater demand for innovative solutions that can effectively tackle complex diseases, including genetic and chronic conditions.

Overall, the business has undergone a revolution thanks to recent technological developments in Oligonucleotides synthesis. Rising technological advancements is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and more advanced medical products in the market. Thereby, the surge in rising technological advancements is expected to create opportunities for market growth.

Restraint / Challenge

Limitation of Oligonucleotides Synthesis

Healthcare professionals rely on clinical evidence to make informed treatment decisions. Limited clinical evidence for oligonucleotides synthesis can lead to hesitancy among healthcare professionals in adopting these techniques. Without sufficient data demonstrating the safety, efficacy, and long-term outcomes of oligonucleotides synthesis, healthcare providers may be less inclined to offer or recommend these procedures to their patients.

Limited clinical evidence may impact rising acceptance and confidence in oligonucleotides synthesis. Patients often rely on evidence-based information to make decisions about their healthcare. Insufficient clinical evidence may lead to skepticism, making healthcare professionals less willing to consider oligonucleotides synthesis as a diagnostic, research, or treatment option. Limitation of oligonucleotides synthesis can hinder the market growth of oligonucleotides synthesis market.

Recent Developments

• In December 2022, Thermo Fisher Scientific, the world leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed to enable rapid and accurate detection and categorization for investigating microorganisms that cause respiratory, vaginal, urinary, gastrointestinal, and sexually transmitted diseases. TrueMark Infectious Disease Research Panels are analytically sensitive, syndromic panels for the analysis of a wide range of infectious disease pathogens. This will help the organization in developing overall revenue.
• In January 2021, Merck KGaA announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). The deal strengthens Merck’s capabilities to develop and manufacture mRNA for its customers for use in vaccines, treatments, and diagnostics applications.
• In April 2019, Agilent Technologies, Inc. launched a new Mass Spectrometry solution Agilent 6546 LC/Q-TOF which is an advanced version of traditional spectroscopy. This will improve the analytical testing of food and also be used in metabolomics research with accurate result.
• In March 2018, DANAHER signed an agreement to acquire Integrated DNA Technologies (IDT) which is a provider of high-value consumables for genomics applications in molecular biology, qPCR synthetic biology, and molecular diagnostics. As a result, there will be an expansion in the genomic market which will increase its product portfolio and revenue.
• In April 2019, Agilent Technologies, Inc. launched a new Mass Spectrometry solution Agilent 6546 LC/Q-TOF which is the advanced version of traditional spectroscopy.

India Oligonucleotides Synthesis Market Scope

India oligonucleotides synthesis market is segmented into six notable segments based on type, product type, synthesis method, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Custom Oligos
• Predesigned Oligos

On the basis of type, the market is segmented into custom oligos and predesigned oligos.

Product Type

• Equipment's
• Reagents, Consumables & Accessories

On the basis of product type, the market is segmented equipment's and reagents, consumables & accessories.

Synthesis Method

• Solid Phase Oligo Synthesis Method
• Liquid/Enzymatic Phase Oligo Synthesis Method

On the basis of the synthesis method, the market is segmented into solid phase oligo synthesis method and liquid/enzymatic phase oligo synthesis method.

Application

• Diagnostics
• Therapeutics
• Research
• Agriculture
• Food
• Others

On the basis of application, the market is segmented into diagnostics, therapeutics, research, agriculture, food, and others.

End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Centers
• Contract Research Organization
• Research & Academic Institutes
• Forensic Labs

On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, diagnostic laboratories, contract research organization, research & academic institutes, forensic labs.

Distribution Channel

• Direct Sales
• Retail Sales
• Others

On the basis of distribution channel, the market is segmented into direct sales, retail sales and others.

Competitive Landscape and India Oligonucleotides Synthesis market Share Analysis

The India oligonucleotides synthesis market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major market players operating in the India oligonucleotides synthesis market are Thermo Fisher Scientific Inc (U.S.), Agilent Technologies Inc (U.S.), Merck KGaA (Germany), Danaher, (U.S.) LGC Limited (U.K.), Eurofins Genomics (India), GENERAL ELECTRIC (U.S.), METTLER TOLEDO (India), TriLink BioTechnologies (U.S.), Ajinomoto Bio-Pharma (Japan), among others.

SKU-70222